171 related articles for article (PubMed ID: 29705090)
1. Alterations in the expression of DNA damage response-related molecules in potentially preneoplastic oral epithelial lesions.
Nikitakis NG; Rassidakis GZ; Tasoulas J; Gkouveris I; Kamperos G; Daskalopoulos A; Sklavounou A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):637-649. PubMed ID: 29705090
[TBL] [Abstract][Full Text] [Related]
2. Management update of potentially premalignant oral epithelial lesions.
Awadallah M; Idle M; Patel K; Kademani D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):628-636. PubMed ID: 29656948
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.
Porter S; Gueiros LA; Leão JC; Fedele S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):603-611. PubMed ID: 29891084
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.
Nikitakis NG; Pentenero M; Georgaki M; Poh CF; Peterson DE; Edwards P; Lingen M; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):650-669. PubMed ID: 29709496
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions.
Yang EC; Tan MT; Schwarz RA; Richards-Kortum RR; Gillenwater AM; Vigneswaran N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):670-681. PubMed ID: 29631985
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic correlations of oral premalignant lesions and squamous cell carcinomas.
Kootman J; El-Mofty SK
J Mo Dent Assoc (1980); 1982; 62(6):33-5. PubMed ID: 6961228
[No Abstract] [Full Text] [Related]
8. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.
Lumerman H; Freedman P; Kerpel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):321-9. PubMed ID: 7621010
[TBL] [Abstract][Full Text] [Related]
9. Premalignant oral mucosal diseases.
Melrose RJ
J Calif Dent Assoc; 2001 Aug; 29(8):593-600. PubMed ID: 11577670
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
11. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
12. Special focus issue on potentially premalignant oral epithelial lesions: introduction and perspective.
Nikitakis NG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):575-576. PubMed ID: 29699945
[No Abstract] [Full Text] [Related]
13. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
15. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
16. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
17. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
Müller S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
[TBL] [Abstract][Full Text] [Related]
18. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
[TBL] [Abstract][Full Text] [Related]
19. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
20. [Precancerous lesions of the buccal mucosa].
Ben Slama L
Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]